<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="utf-8">
    <meta http-equiv="X-UA-Compatible" content="IE=edge">
    <meta content="width=device-width, initial-scale=1, maximum-scale=1, user-scalable=no" name="viewport">
    <meta name="description" content="نظام معلومات الأدوية السعودي Saudi Drugs Information System">
    <meta name="author" content="Saudi Food & Drug Authority (SFDA)">
    <noscript><meta http-equiv="refresh" content="0; url=/noScript.html" /></noscript>
    <link rel="shortcut icon" href="/favicon.ico">
    <title>&#x646;&#x638;&#x627;&#x645; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</title>
    <link href="/fonts/roboto/roboto.css?v=53F8z0aw8DRnG9ou9x1tuKMPbNjRZWM-VBHl3B0s9-o" rel="stylesheet" />
    <link href="/fonts/material-icons/materialicons.css?v=8pEJ8MWsFzHRDLY0NI5rssf6T6vankxrJDPnnZxOGrg" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-rtl.css?v=0env-Atj9mTPLILmJGwuDlLIOS_Akxxy4gnH1UUtrjU" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-glyphicons.css?v=U5a39oen_WYzVAAexH5aoahbpqlKHcIzQrnXujf1yio" rel="stylesheet" />
    <link href="/lib/bootstrap-select/dist/css/bootstrap-select.css?v=DeY2lH0e0tmNnO9XZ-gGVOGk6_YoWlZ49y7CnD3ST00" rel="stylesheet" />
    <link href="/lib/toastr/toastr.css?v=kKePN_CyxTiMEgsSDu_7z21ru07YOZtR-0UV0JOkt5o" rel="stylesheet" />
    <link href="/lib/famfamfam-flags/dist/sprite/famfamfam-flags.css?v=JVJiF3s2_kk99xQHfYhfxo_-Dd52ZIruDMOILwPkqv0" rel="stylesheet" />
    <link href="/lib/font-awesome/css/font-awesome.css?v=YIHlqxkiJtENTMuzIHC9EfZaB5RniGr7kF7juUQJUuc" rel="stylesheet" />
    <link href="/lib/Waves/dist/waves.css?v=nd3hxjNg6DhkuFIz5IbxLK8Xw2ac0blsDQpF4pkJxUc" rel="stylesheet" />
    <link href="/lib/animate.css/animate.css?v=IT6GQizZpVcaM1_L_mIiNAYVvZErMgfwewf1GGWXG_I" rel="stylesheet" />
    <link href="/css/materialize.css?v=ey-J3xahkqficOYUHVX3jexmzvRFrge9bmux4CQr1DQ" rel="stylesheet" />
    <link href="/css/Publicstyle.css?v=xhOiVjq-54ODzSIeHXoascHsEJm_n_bIHqZatpxnYhg" rel="stylesheet">
    <link href="/css/Comman.css?v=bcS6_IRqBsBcY1mS_iriWWanrYR0Scdo1ffk8rQGXwQ" rel="stylesheet" />
    <link href="/css/themes/all-themes.css?v=eGSl5zNTWrXYfUx_EJW9ksC3CUTUUxvxmPiA3aQDtQo" rel="stylesheet" />
    <link href="/view-resources/Views/Shared/_Layout.css?v=BLxBuNISlF2O5EBHWdsX039NvnIHy-GtcqeI_MbyIc0" rel="stylesheet" />
    <link href="/lib/enjoyhint/enjoyhint.css?v=rSxIyBbiAvx_48ZcFxbn2DNPCCgEc0FXa2Vb72enxk4" rel="stylesheet" />
    <link href="/lib/dropzone/dropzone.css?v=IQDlHJdeYZ4gMH87EuB1yEG7ujA7DSEkV_SWfACk8Rg" rel="stylesheet" />

    <!-- View specific styles -->
    
    <script type="text/javascript" nonce="c7f26c8w">
        // This is used to get the application's root path from javascript. It's useful if you're running application in a virtual directory under IIS.
        var abp = abp || {};
        abp.appPath = '/';

    </script>
    <style>
        .popover .popover-title {
            text-align: right;
            font-weight: bold;
        }
        .popover .popover-content {
            text-align: right;
            font-size: 14px;
            font-family: 'Almarai', sans-serif;
            color: black;
        }
       
    </style>
</head>
<body>
    <!-- Page Loader -->
    <div class="page-loader-wrapper">
        <div class="loader">
            <div class="preloader">
                <div class="spinner-layer pl-blue">
                    <div class="circle-clipper left">
                        <div class="circle"></div>
                    </div>
                    <div class="circle-clipper right">
                        <div class="circle"></div>
                    </div>
                </div>
            </div>
            <p>&#x628;&#x631;&#x62C;&#x627;&#x621; &#x627;&#x644;&#x625;&#x646;&#x62A;&#x638;&#x627;&#x631; ...</p>
        </div>
    </div>
    <!-- #END# Page Loader -->
    <!-- Overlay For Sidebars -->
    <div class="overlay"></div>
    <!-- #END# Overlay For Sidebars -->
    <!-- Search Bar -->
    <!-- Top Bar -->
    <nav class="navbar navbar-inverse naav" style="margin-bottom: 0;">
        <div class="container-fluid">
            <div class="navbar-header">
                <button type="button" class="navbar-toggle" data-toggle="collapse" data-target="#myNavbar">
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                </button>
            </div>
            <div class="collapse navbar-collapse rtl" id="navbar-collapse">
                <ul class="nav navbar-nav navbar-right">
                    <li><a href="/home/DrugSearch">&#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</a></li>
                        <li><a href="/Account/Login"><i class="fa fa-key"></i>&nbsp;&#x62A;&#x633;&#x62C;&#x64A;&#x644; &#x627;&#x644;&#x62F;&#x62E;&#x648;&#x644;</a></li>
                </ul>
                <ul class="nav navbar-nav navbar-left">
                    <li class="dropdown">
    <a href="javascript:void(0);" class="dropdown-toggle" data-toggle="dropdown" role="button">
        <i class="famfamfam-flags sa" title="&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;"></i>
        <span>&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</span>
        <b class="caret"></b>
    </a>
    <ul class="dropdown-menu pull-right">
                <li><a href="/AbpLocalization/ChangeCulture?cultureName=en"><i class="famfamfam-flags gb"></i> English</a></li>

    </ul>
</li>

                </ul>
            </div>
        </div>
    </nav>
    <section id="mainContent" class="content">
        <nav class="navbar naav" style="margin-bottom: 0;">
            <div class="container-fluid">
                <ul class="nav navbar-nav">
                    <li>
                        <a class="text-center" href="/">
                            <img src="/images/logo_sdi.png" style="margin: auto;" width="250">
                        </a>
                    </li>
                </ul>
                <div class="navbar-header navbar-toggle2 ">
                    <button type="button" class="navbar-toggle navbar-toggle2" data-toggle="collapse"
                            data-target="#myNavbar2">
                        <span class="icon-bar icon-bar2 "></span>
                        <span class="icon-bar icon-bar2"></span>
                        <span class="icon-bar icon-bar2"></span>
                    </button>
                </div>
                <div class="collapse navbar-collapse " id="myNavbar2">
                    <ul class="nav navbar-nav">
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover" data-placement="bottom" title="" data-content="موقع الكترونى يمكن شركات ووكلاء الادويه من رفع النشرات الممارس الصحى ونشرة معلومات المريض وصورة عبوة الدواء المعتمدة من الهيئة العامة للعذاء والدواء بهدف بناء مرجع وطنى للادوية المسجلة يمكن الرجوع له من قبل الممارس الصحى والمريض كمصدر موثوق للمعلومات الدوائية"
                               data-original-title="&#x645;&#x646; &#x646;&#x62D;&#x646;">
                                &#x645;&#x646; &#x646;&#x62D;&#x646;
                            </a>
                        </li>
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover"
                               data-placement="bottom"
                               title=""
                               data-content="&#x627;&#x630;&#x627; &#x643;&#x627;&#x646; &#x644;&#x62F;&#x64A;&#x643;&#x645; &#x645;&#x644;&#x627;&#x62D;&#x638;&#x627;&#x62A; &#x627;&#x648; &#x627;&#x642;&#x62A;&#x631;&#x627;&#x62D;&#x627;&#x62A; &#x64A;&#x631;&#x62C;&#x649; &#x627;&#x644;&#x62A;&#x648;&#x627;&#x635;&#x644; &#x639;&#x644;&#x649;   SDI@SFDA.GOV.SA"
                               data-original-title="&#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;">
                                &#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;
                            </a>
                        </li>

                    </ul>
                </div>
            </div>
        </nav>
        

<div class="col-xs-12">
    <div class="row text-center">
        <a href="/" class="btn bg-blue btn-lg m-b-10 hover-white">&#x628;&#x62D;&#x62B; &#x62C;&#x62F;&#x64A;&#x62F;</a>
    </div>
</div>
<div class="jumbotron" style="margin-bottom: 0px; background-color: white !important;">
    <h3 class="text-center" style="color: #57aabf; ">Search Results</h3>
    <hr width="20%" style="border-top: 3px solid #54ae90;">

    <br>
    <table class="table s-row">
        <thead style="margin-bottom: 30px !important">
                <tr>
                    <th id="M" style="color:white;">
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x627;&#x644;&#x645;&#x645;&#x627;&#x631;&#x633; &#x627;&#x644;&#x635;&#x62D;&#x64A;</a>
                    </th>
                    <th id="A" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</a>
                    </th>
                    <th id="E" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x627;&#x646;&#x62C;&#x644;&#x64A;&#x632;&#x64A;&#x629;</a>
                    </th>
                    <th id="f" class="active-tab" type='button'>
                        <a href="javascript:void(0)" style="color: white;">&#x635;&#x648;&#x631; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>
                    <th id="D" style="color:white; background-color: #47a4ba;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x628;&#x64A;&#x627;&#x646;&#x627;&#x62A; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>

                </tr>
        </thead>
    </table>
    <div id="D-div" class="box-data" style="display: block;">
        <div class="row">

<div class="modal-body rtl">
    <div class="tab-content">
        <div role="tabpanel" class="tab-pane m-r-60  animated fadeIn active" id="edit-user-details">
<div class="row clearfix">
                    <div class="col-lg-6 col-md-6 col-sm-6">
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="RegisterNumber">&#x631;&#x642;&#x645; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        3110211252
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="RegisterYear">&#x633;&#x646;&#x629; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        2002
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="TradeName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x62A;&#x62C;&#x627;&#x631;&#x64A;</label>
                                    <div class="form-line">
                                        SAPOFEN 200MG F.C TAB
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="ScientificName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x639;&#x644;&#x645;&#x64A;</label>
                                    <div class="form-line">
                                        IBUPROFEN
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label " for="Strength">&#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        200
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="StrengthUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        mg
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="AdministrationRouteName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x625;&#x633;&#x62A;&#x639;&#x645;&#x627;&#x644;</label>
                                    <div class="form-line">
                                        Oral use
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PharmaceuticalFormName">&#x627;&#x644;&#x634;&#x643;&#x644; &#x627;&#x644;&#x635;&#x64A;&#x62F;&#x644;&#x627;&#x646;&#x64A;</label>
                                    <div class="form-line">
                                        Film-coated tablet
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Size">&#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="SizeUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageSize">&#x62D;&#x62C;&#x645; &#x627;&#x644;&#x639;&#x628;&#x648;&#x629;</label>
                                    <div class="form-line">
                                        30
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageTypeName">&#x627;&#x646;&#x648;&#x627;&#x639; &#x627;&#x644;&#x639;&#x628;&#x648;&#x627;&#x62A;</label>
                                    <div class="form-line">
                                        Blister
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="LegalStatusName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x635;&#x631;&#x641;</label>
                                    <div class="form-line">
                                        OTC
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="ProductControlName">&#x62D;&#x627;&#x644;&#x629; &#x627;&#x644;&#x645;&#x631;&#x627;&#x642;&#x628;&#x629;</label>
                                    <div class="form-line">
                                        Uncontrolled
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="DrugTypeName">&#x646;&#x648;&#x639; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</label>
                                    <div class="form-line">
                                        Generic
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="ShelfLife">&#x645;&#x62F;&#x629; &#x627;&#x644;&#x635;&#x644;&#x627;&#x62D;&#x64A;&#x629; &#x628;&#x627;&#x644;&#x623;&#x634;&#x647;&#x631;</label>
                                    <div class="form-line">
                                        36
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="StorageConditionsName">&#x634;&#x631;&#x648;&#x637; &#x627;&#x644;&#x62A;&#x62E;&#x632;&#x64A;&#x646;</label>
                                    <div class="form-line">
                                        store below 30°c
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Price">&#x633;&#x639;&#x631; &#x627;&#x644;&#x62C;&#x645;&#x647;&#x648;&#x631; &#x628;&#x627;&#x644;&#x631;&#x64A;&#x627;&#x644;  ( &#x627;&#x644;&#x633;&#x639;&#x631; )</label>
                                    <div class="form-line">
                                        5.05
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Manufacture_NameEn" name="Manufacture.NameEn" value="SPIMACO" />
                                        <label class="form-label" for="Manufacture_NameEn">&#x627;&#x644;&#x645;&#x635;&#x646;&#x639;</label>
                                        <div class="form-line">
                                            SPIMACO
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Agent" name="Agent" value="[Agent 488]" />
                                        <label class="form-label">&#x627;&#x644;&#x648;&#x643;&#x64A;&#x644;</label>
                                        <div class="form-line">
                                            SPIMACO
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <label class="form-label" for="Company_NameEn">&#x627;&#x644;&#x634;&#x631;&#x643;&#x629; &#x627;&#x644;&#x645;&#x633;&#x648;&#x642;&#x629;</label>
                                        <div class="form-line">
                                            SPIMACO ADDWAEIH
                                        </div>
                                    </div>
                                </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode1">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 1</label>
                                    <div class="form-line">
                                        M01AE01
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode2">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 2</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                    </div>
                </div>
        </div>
    </div>
</div>

        </div>
    </div>
    <div id="E-div" class="box-data">
<div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue  m-t-20 m-b-20 ltr">
                <i class="fa fa-info-circle"></i>&nbsp;
                <span style="font-size: large; background-color: rgb(245,245,245); color: rgb(51,51,51); "> SFDA PIL</span>
                <span style="font-size:small;">  (Patient Information Leaflet (PIL) are under review by Saudi Food and Drug Authority)</span>

            </div>
</div>


<div class="clearfix ltr">
    <div class="col-lg-12 col-md-12 col-sm-12 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="InventedNameEn">1. What this product is and what it is used for</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>This medicine contains Ibuprofen which belongs to a group of medicines called non-steroidal anti-inflammatory drugs (NSAIDs), which act to relieve pain and reduce swelling. It can be used to relieve headaches, rheumatic and muscular pain, backache, migraine, period pain, dental pain and neuralgia. It can also be used to reduce fever and relieve the symptoms of colds and flu.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="form-group clearfix">
            <label style="float: left" class="h2" for="PrecautionsEn">2. What you need to know before you use this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>This medicine can be taken by adults and children aged 12 years and over. However, some people should not take this medicine or should seek the advice of their pharmacist or doctor first.</p><p>&middot; Do not take this medicine:</p><p>- If you have a stomach ulcer, perforation or bleeding, or have had one, twice or more in the past.</p><p>- If you have had perforation or a bleeding stomach after taking a non-steroidal anti-inflammatory medicine (you may have been sick and it contained blood or dark particles that look like coffee grounds, passed blood in your stools or passed black tarry stools).</p><p>- If you are allergic to ibuprofen or any other ingredients of the product, aspirin or other non-steroidal anti-inflammatory medicines (you have ever had asthma, runny nose, itchy skin or swelling of the lips, face or throat after taking these medicines).</p><p>- If you are taking aspirin with a daily dose above 75 mg, or other non-steroidal anti-inflammatory medicines.</p><p>- If you have severe heart, kidney or liver failure.</p><p>- If you are pregnant, and in the last 3 months of pregnancy.</p><p>&nbsp;</p><p>Talk to your pharmacist or doctor:</p><p>- If you have asthma, a history of asthma or other allergic disease, bowel problems, ulcerative colitis, Crohn&rsquo;s disease.</p><p>- If your headaches become persistent.</p><p>- If you have other kidney, heart or liver problems (see &ldquo;Do not take&rdquo;).</p><p>- If you have a connective tissue disorder such as SLE (Systemic Lupus Erythematosus).</p><p>- If you have chickenpox.</p><p>- If you are elderly &ndash; you may get more side effects.</p><p>- If you are taking any other painkillers or receiving regular treatment from your doctor.</p><p>- If you have had a stroke, or have heart problems, high blood pressure, diabetes, high cholesterol, or you smoke &ndash; see &lsquo;Risk of heart attack or stroke&rsquo; below.</p><p>- If you are pregnant, and in the first 6 months of pregnancy.</p><p>- If you are breastfeeding.</p><p>- If you are suffering from, or with a previous history of bronchial asthma since NSAIDs have been reported to cause bronchospasm in such patients.</p><p>- If you are with a history of cholecystectomy as it may cause acute pancreatitis in some patients.</p><p>- If symptoms persist.</p><p>- If you have oedema as it has been reported in association with NSAID administration.</p><p>- If you have a history of hypertension and/or mild to moderate congestive heart failure as fluid retention and oedema have been reported in association with NSAID therapy.</p><p>&nbsp;</p><p>Other important information:</p><p>Risk of heart attack or stroke: Ibuprofen may increase the risk if you take large amounts for a long time. The risk is small. Take the lowest amount for the shortest possible time to reduce this risk.</p><p>Woman of childbearing age: If you take this medicine, it may reduce your ability to become pregnant. This effect will be reversed when you stop taking the medicine.</p><p>If you take other medicines:</p><p>Before you take these tablets, make sure that you tell your pharmacist about ANY other medicines you might be using at the same time, particularly the following:</p><p>- Other pain killers (including NSAIDs).</p><p>- Paracetamol containing products</p><p>- Aspirin 75 mg (to prevent heart attacks or strokes).</p><p>- Medicines to thin your blood (e.g. warfarin).</p><p>- Mifepristone (for termination of pregnancy) &ndash; do not take ibuprofen if you have taken mifepristone in the last 12 days.</p><p>- Water tablets (diuretics), medicines to treat high blood pressure, medicines for heart problems.</p><p>- Corticosteroids, lithium, methotrexate, zidovudine.</p><p>- Quinolone antibiotics (for infections).</p><p>- Medicines for depression (including SSRIs).</p><p>- Ciclosporin or tacrolimus (given after transplant surgery, or for psoriasis or rheumatism).</p><p>- Excessive intake of caffeine (e.g. coffee, tea and some canned drinks).</p><p>- This medicine is for the short term treatment of acute moderate pain when other painkillers have not worked.</p><p>&nbsp;</p><p>If you are unsure about interactions with any other medicines, talk to your pharmacist. This includes medicines prescribed by your doctor and medicine you have bought for yourself, including herbal and homeopathic remedies.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="AdministrationRoutesEn">3. How to use this product.</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Check the foil is not broken before first use. If it is, do not take that tablet.</p><table border="1" cellspacing="1" cellpadding="1" style="width:1000px"><tbody><tr><td>Age</td><td style="width:336px">How many to take</td><td style="width:329px">How often to take them</td></tr><tr><td><p>Adults and children of 12</p><p>years and over.</p></td><td style="width:336px">One or two tablets.</td><td style="width:329px">Every 4 hours, if you need to. Don&rsquo;t take more than 6 tablets in 24 hours.</td></tr><tr><td colspan="3">Take the lowest amount for the shortest possible time to relieve your symptoms.</td></tr></tbody></table><p>Swallow each tablet with water. Do not give to children under 12 years. Do not take more than the amount recommended above. If your symptoms worsen at any time, talk to your doctor. If your symptoms do not go away within 10 days, talk to your doctor. If you take too many tablets: Talk to a doctor straight away. Take your medicine and this leaflet with you.</p><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsEn">4. Possible side effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Most people will not have problems, but some may get some. If you are elderly you may be more likely to have some of these side effects. Gastrointestinal: the most commonly-observed adverse events are gastrointestinal in nature. Nausea, vomiting, diarrhoea, dyspepsia, abdominal pain, melena, haematemesis, ulcerative stomatitis and gastrointestinal haemorrhage have been reported following ibuprofen administration. Less frequently, gastritis, duodenal ulcer, gastric ulcer and gastrointestinal perforation have been observed. Epidemiological data indicate that of the seven most widely used oral, non-aspirin NSAIDs; ibuprofen presents the lowest risk of upper gastrointestinal toxicity. Hypersensitivity: hypersensitivity reactions have been reported following treatment with ibuprofen. These may consist of: (a) Non-specific allergic reaction and anaphylaxis, (b) Respiratory tract reactivity comprising asthma, aggravated asthma, bronchospasm or dyspnoea, or (c) Assorted skin disorders, including rashes of various types, pruritus, urticaria, purpura, angioedema and, less commonly, bullous dermatoses (including epidermal necrolysis and erythema multiforme). Cardiovascular: Oedema, hypertension and cardiac failure have been reported in association with NSAID treatment. Clinical trial and epidemiological data suggest that use of ibuprofen, particularly at high dose (2400 mg/ daily), and in long term treatment may be associated with a small increased risk of arterial thrombotic events (for example myocardial infarction or stroke). Overall, epidemiological studies do not suggest that low dose ibuprofen (e.g. &le; 1200mg daily) is associated with an increased risk of myocardial infarction. Patients with uncontrolled hypertension, congestive heart failure, established ischaemic heart disease, peripheral arterial disease, and/or cerebrovascular disease should only be treated with ibuprofen after careful consideration. Similar consideration should be made before initiating longer-term treatment of patients with risk factors for cardiovascular events (e.g. hypertension, hyperlipidaemia, diabetes mellitus, smoking). Other adverse events reported less commonly and for which causality has not necessarily been established include: Renal: nephrotoxicity in various forms, including interstitial nephritis, nephrotic syndrome and renal failure. Hepatic: abnormal liver function, hepatitis and jaundice. Neurological and special senses: visual disturbances, optic neuritis, headaches, paraesthesia, depression, confusion, hallucinations, tinnitus, vertigo, dizziness, malaise, fatigue and drowsiness. Haematological: thrombocytopenia, neutropenia, agranulocytosis, aplastic anaemia and haemolytic anaemia. Dermatological: photosensitivity.</p><p>Undesirable effects may be minimised by using the lowest effective dose for the shortest duration necessary to control symptoms.</p><p>If any side effect becomes severe, or you notice any side effect not listed here, stop taking this medicine and tell your pharmacist or doctor.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsEn">5. How to store this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Sapoefen 200 mg : store below 25&deg;C.</p><p>Store in the original package.</p><p>Keep this medicine in a safe place out of the sight and reach of children, preferably in a locked cupboard.</p><p>Do not use this medicine after the expiry date that is printed on the pack. The expiry date refers to the last day of that month.</p><p>Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of medicines no longer required. These measures will help to protect the environment</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. Further information</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsEn">a. What this product contains</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>&middot; Sapofen 200 mg. Film-coated tablets: Each film-coated tablet contains Ibuprofen 200 mg, which is the active ingredient.</p><p>Other ingredients:</p><p>&middot; Tablet core: Hydroxypropyl Cellulose, Colloidal Silicon Dioxide, Avicel PH 101, Sodium Lauryl Sulphate, Croscarmellose Sodium Type A, Avicel PH 102, Purified Talc, Polysorbate 80, Titanium Dioxide, Polyethylene Glycol and Hydroxypropyl Methylcellulose.</p><p>&middot; Coating Material: Opadry Dark Orange and Purified Water.</p><p>What this medicine looks like:</p><p>Sapofen 200mg</p><p>FCTablets A white to off white, round, biconvex, film coated tablet with &ldquo;177&rdquo; on one side and plain on the other side.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsEn">b. What this product looks like and contents of the pack</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                Sapoefen 200 mg. film-coated tablets: each pack contains 30 tablets.
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingEn">c. Marketing Authorization Holder and Manufacturer</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>SPIMACO</p><p>AlQassim pharmaceutical plant</p><p>Saudi Pharmaceutical Industries &amp;</p><p>Medical Appliance Corporation</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteEn">d. This leaflet was last revised in {MM/YYYY}</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                November 2016.
            </div>
        </div>
    </div>
</div>    </div>
    <div id="A-div" class="box-data">
<div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue  m-t-20 m-b-20 ltr">
                <i class="fa fa-info-circle"></i>&nbsp;
                <span style="font-size: large; background-color: rgb(245,245,245); color: rgb(51,51,51); "> نشرة الدواء تحت مراجعة الهيئة العامة للغذاء والدواء</span>
                <span style="font-size:small;">  (اقرأ هذه النشرة بعناية قبل البدء في استخدام هذا المنتج لأنه يحتوي على معلومات مهمة لك)</span>
            </div>
    <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr">

    </div>

</div>
<div class="clearfix rtl">
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="InventedNameAr">1. ما ھو هذا المستحضر وماھي دواعي استعماله</label>
        </div>
        <div class="form-group clearfix" style="float: right">
            <br />
            <p>هذا الدواء يحتوى على مادة أيبوبروفين والتى تنتمى إلى مجموعة من الأدوية التى تعرف باسم مضادات الالتهاب غير الإستيرويدية (NSAIDs) والتى تعمل على الحد من الألم وتخفيف التورم.</p><p>يمكن استخدام هذا الدواء للحد من آلام الصداع وآلام الروماتيزم وآلام العضلات وآلام الظهر والصداع النصفى وآلام الدورة الشهرية وآلام الأسنان والألم العصبي. ويمكن أن يستخدم أيضاً للتخفيف من أعراض البرد والأنفلونزا وخفض الحمى.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="PrecautionsAr">2. ما الذي يجب عليك معرفته قبل استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p>يمكن تناول هذا الدواء من قبل البالغين والأطفال فى سن 12 سنة من العمر فما أكثر. ومع ذلك, ينبغى على بعض الناس عدم تناول هذا الدواء أو استشارة الطبيب المعالج أو الصيدلى قبل البدء فى تناول هذا الدواء.</p><p>&middot; لا تقم بتناول هذا الدواء فى الحالات الآتية:</p><p>- إذا كنت تعاني من قرحة في المعدة, أو انثقاب أو نزيف, أو أصبت بإحدى هذا الحالات مرتين أو أكثر فى الماضى.</p><p>- إذا أصبت مسبقاً بقرحة بالمعدة أو انثقاب أو نزيف بالمعدة بعد تناولك أى دواء من مجموعة مضادات الالتهاب غير الإستيرويدية (فقد تكون مريضاً ولديك دم أو جزيئات قاتمة اللون تشبه حبيبات القهوة بالبراز أو لديك براز لونه أسود قطرانى).</p><p>- إذا كنت تعانى من فرط التحسس تجاه مادة أيبوبروفين أو أى من المكونات الأخرى لهذا الدواء أو الأسبرين أو أى دواء آخر من مجموعة مضادات الالتهاب غير الإستيرويدية (على سبيل المثال إذا تعرضت لحساسية بالصدر أو رشح بالأنف أو حكة بالجلد أو تورم بالشفتين أو الوجه أو الحلق بعد تناول تلك الأدوية).</p><p>- إذا كنت تتناول جرعة يومية أكبر من 75 ملجم أو أى دواء آخر من مجموعة مضادات الالتهاب غير الإستيرويدية.</p><p>- إذا كنت تعانى من فشل حاد بالقلب أو الكبد أو الكلى.</p><p>- إذا كنتِ حاملاً, وفى الثلاثة أشهر الأخيرة من الحمل.</p><p>تواصل مع طبيبك المعالج أو الصيدلى فى الحالات الآتية:</p><p>&middot; إذا كنت تعانى من الربو أو لديك تاريخ من الإصابة بالربو مسبقاً أو أى مرض تحسسى آخر أو إذا كنت تعانى من مشاكل بالقولون, أو لديك التهاب تقرحى بالقولون أو مرض كرون.</p><p>&middot; فى حالة استمرار الصداع لديك.</p><p>&middot; إذا كنت تعانى من مشاكل أخرى بالكلى أو القلب أو الكبد (انظر أعلاه فقرة &quot;لا تقم بتناول هذا الدواء&quot;).</p><p>&middot; إذا كنت تعانى من اضطرابات النسيج الضام مثل الذئبة الحمراء (الذئبة الحمراء الجهازية).</p><p>&middot; إذا كنت تعانى من الجدري المائى.</p><p>&middot; إذا كنت من كبار السن- حيث قد تكون أكثر عرضة لحدوث الأعراض الجانبية.</p><p>&middot; إذا كنت تتناول مسكنات أخرى للألم أو تتبع نظام علاجى من قبل طبيبك المعالج.</p><p>&middot; إذا أصبت مسبقاً بالسكتة الدماغية، أو لديك مشاكل في القلب أو ارتفاع فى ضغط الدم، أو مرض السكري، أو ارتفاع مستوى الكولسترول أو إذا كنت من المدخنين - انظر &quot;مخاطر الإصابة بالنوبات القلبية أو السكتة الدماغية&quot; أدناه.</p><p>&middot; إذا كنتِ حاملاً, وفى الستة أشهر الأولى من الحمل.</p><p>&middot; إذا كنتِ ترضعين طفلك طبيعياً.</p><p>&middot; إذا كنت تعانى من الربو أو لديك تاريخ مسبق من الإصابة بالربو حيث قد تم رصد حدوث تشنج قصبى فى مثل هؤلاء المرضى عند استخدام مضادات الالتهاب غير الإستيرويدية.</p><p>&middot; إذا كان لديك تاريخ من استئصال المرارة لأنها قد تسبب التهاب البنكرياس الحاد في بعض المرضى.</p><p>&middot; فى حالة استمرار الأعراض لديك.</p><p>&middot; إذا كنت تعانى من وذمة حيث تم الإبلاغ عن حدوث الوذمة مع استخدام مضادات الالتهاب غير الإستيرويدية.</p><p>&middot; إذا كان لديك تاريخ من الإصابة بارتفاع ضغط الدم و / أو فشل القلب الاحتقانى الخفيف إلى المتوسط حيث تم الإبلاغ عن حدوث احتباس للسوائل وحدوث الوذمة مع استخدام مضادات الالتهاب غير الإستيرويدية.</p><p>&nbsp;</p><p>معلومات أخرى هامة:</p><p>خطر الإصابة بالنوبات القلبية أو السكتة الدماغية: أيبوبروفين قد يزيد من هذا الخطر فى حالة تناول جرعات كبيرة لفترة طويلة. لذلك ينبغى تناول أقل جرعة ممكنة لأقل وقت ممكن للحد من هذه الخطورة.</p><p>&nbsp;</p><p>إحتمالات الخطورة علي الجهاز الدورى :</p><p>&middot; يمكن أن يحدث خطر الاصابة بالنوبات القلبية أو السكتة الدماغية في وقت مبكر بقدر الأسبوع الأول من استخدام الأدوية غير الستيرويدية المضادة للالتهاب. قد تزيد هذه الخطورة مع استخدام الأدوية غير الستيرويدية المضادة للالتهاب لفترة أطول.</p><p>&middot; تزداد فرص ظهور الخطورة عند تناول جرعات أعلى.</p><p>&middot; خطورة الاصابة بالازمات القلبية أو السكتة الدماغية هي متشابهة لجميع الأدوية غير الستيرويدية المضادة للالتهاب.</p><p>&middot; الأدوية غير الستيرويدية المضادة للالتهاب يمكن أن تزيد من خطر الاصابة بالنوبات القلبية أو السكتة الدماغية في المرضى سواء كانوا يعانون أو لا يعانون من أمراض القلب أو عوامل خطرة مسببة لأمراض القلب. وهناك عدد كبير من الدراسات تدعم هذه النتيجة، مع تقديرات متفاوتة لمعرفة إلي أي مدي قد تزداد الخطورة، اعتمادا على الأدوية والجرعات التي تمت دراستها.</p><p>&middot; بشكل عام، تزداد احتمالية الإصابة بالنوبة القلبية أو السكتة الدماغية لدي المرضى الذين يعانون من أمراض القلب أو عوامل خطرة قد تؤدي لأمراض القلب بعد استخدام الأدوية غير الستيرويدية المضادة للالتهاب مقارنة بالمرضى الذين لا يعانون من أي عوامل خطرة وهذا لأن لديهم خطورة أعلي في الأساس.</p><p>&middot; المرضى الذين تم علاجهم باستخدام مضادات الالتهاب غير الستيرويدية عقب إصابتهم بأزمة قلبية لأول مرة أكثر عرضة للوفاة في السنة الأولى بعد النوبة القلبية مقارنة بالمرضى الذين لم يتم علاجهم باستخدام مضادات الالتهاب غير الستيرويدية بعد أول نوبة قلبية.</p><p>&middot; هناك خطر متزايد لحدوث فشل في القلب مع استخدام الأدوية غير الستيرويدية المضادة للالتهاب.</p><p>&nbsp;</p><p>بالنسبة للسيدات فى سن الإنجاب: تناولك لهذا الدواء قد يقلل من احتمالية الحمل لديك. وسوف يتم عكس هذا التأثير بمجرد التوقف عن تناول هذا الدواء.</p><p>فى حالة تناول أدوية أخرى:</p><p>قبل البدء فى تناول هذا الدواء, تأكد من إبلاغ الصيدلى بشأن أى أدوية أخرى تتناولها فى نفس الوقت, خصوصاً الأدوية التالية:</p><p>&middot; مسكنات أخرى للألم (بما فيها مضادات الالتهاب غير الإستيرويدية).</p><p>&middot; أدوية أخرى تحتوى على باراسيتامول.</p><p>&middot; أسبرين 75 ملجم (للوقاية من نوبات القلب أو السكتة الدماغية).</p><p>&middot; أدوية تعمل على ترقيق الدم (مثل الوارفارين).</p><p>&middot; ميفيبريستون (لإنهاء الحمل)- حيث يحظر استخدام أيبوبروفين فى حالة استخدام ميفيبريستون فى خلال 12 يوماً الماضية.</p><p>&middot; أقراص الماء (مدرات البول), أو أدوية لعلاج ارتفاع ضغط الدم, أو أدوية لعلاج مشاكل القلب.</p><p>&middot; الكورتيكوستيرويدات, أو الليثيوم, أو ميثوتريكسات, أو زيدوفودين.</p><p>&middot; المضادات الحيوية من مجموعة الكينولونات (لعلاج العدوى البكتيرية).</p><p>&middot; أدوية لعلاج الاكتئاب (وتشمل مجموعة مثبطات السيروتونين الانتقائية).</p><p>&middot; سيكلوسبورين أو تاكروليموس (وهى أدوية تستخدم بعد عملية زرع الأعضاء أو مرض الصدفية أو الروماتيزم).</p><p>&middot; الإفراط في تناول الكافيين (مثل القهوة والشاي وبعض المشروبات المعلبة).</p><p>&middot; يستخدم هذا الدواء كعلاج قصير المدى للألم الحاد المعتدل فى حالة عدم نجاح مسكنات الألم الأخرى.</p><p>فى حالة عدم تأكدك من تفاعلات هذا الدواء مع أى أدوية أخرى, تواصل مع الصيدلى. يشمل ذلك الأدوية الموصوفة لك من قبل الطبيب والأدوية التى حصلت عليها بدون وصفة طبية والأدوية العشبية والعلاجات المثلية.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            https://localhost:44358/Dashboard
            <label class="h2" for="AdministrationRoutesAr">3. ماھي طريقة استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p>تأكد من سلامة الشريط قبل استخدام هذا الدواء. فى حالة عدم سلامة الشريط لا تقم بتناول هذا الدواء.</p><table border="1" align="right" cellspacing="1" cellpadding="1" style="width:1000px"><tbody><tr><td style="width:326px">عدد المرات</td><td style="width:338px">الجرعة</td><td>العمر</td></tr><tr><td style="width:326px">كل 4 ساعات, عند الحاجة إلى ذلك. لا تقم بتناول أكثر من 6 أقراص باليوم الواحد.</td><td style="width:338px">قرص واحد أو قرصين.</td><td><p>فى حالة البالغين والأطفال فى سن</p><p>12سنة من العمر فما أكثر.</p></td></tr><tr><td colspan="3" style="width:326px">ينبغى عليك تناول أقل جرعة ممكنة لأقل وقت ممكن للتخلص من الأعراض التى لديك.</td></tr></tbody></table><p>&nbsp;</p><p>&nbsp;</p><p>&nbsp;</p><p>&nbsp;</p><p>قم بابتلاع القرص مع الماء.</p><p>لا يستخدم هذا الدواء للأطفال الأقل فى العمر من 12 سنة.</p><p>لا تقم بتناول جرعة أكبر من تلك الموصوفة بالجدول أعلاه.</p><p>فى حالة تفاقم الأعراض لديك فى أى وقت, تواصل مع طبيبك المعالج.</p><p>فى حالة عدم زوال الأعراض لديك فى خلال 10 أيام, تواصل مع طبيبك المعالج.</p><p>فى حالة تناولك العديد من تلك الأقراص: تواصل مع طبيبك المعالج فى الحال. خذ معك هذا الدواء وهذه النشرة لمساعدة الطبيب فى التعرف على الدواء.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsAr">4. الأعراض الجانبية المحتملة</label>
        </div>
        <div class="m-r-60">
            <p>من الطبيعى عدم تعرض معظم الناس لأى مشاكل, ومع ذلك قد يتعرض بعض الناس لبعض الأعراض الجانبية لهذا الدواء.</p><p>إذا كنت من كبار السن فقد تكون أكثر عرضة لحدوث بعض هذه الأعراض الجانبية.</p><p>أعراض الجهاز الهضمى: الأعراض الأكثر شيوعاً تتعلق بالجهاز الهضمى فى طبيعتها. وهى غثيان, تقيؤ, إسهال, عسر هضم, ألم بالبطن, تغوط أسود, قيء دموي, وقد تم الإبلاغ عن التهاب الفم التقرحي ونزيف الجهاز الهضمي بعد تناول أيبوبروفين. والأعراض الأقل شيوعاً التى قد تم رصدها هى التهاب المعدة, وقرحة الأمعاء, وقرحة المعدة, وانثقاب الجهاز الهضمى. تشير المعطيات الوبائية أن من السبعة الأكثر استخداماً على نطاق واسع عن طريق الفم من مجموعة مضادات الالتهاب غير الإستيرويدية خلاف الأسبرين, فإن أيبوبروفين يشكل الحد الأدنى من خطر إصابة الجهاز الهضمى العلوى.</p><p>فرط الحساسية: قد تم الإبلاغ عن أعراض تفاعلات فرط الحساسية عقب استخدام أيبوبروفين. والتى قد تتكون من:</p><p>a) تفاعلات تحسسية غير محددة وحساسية مفرطة,</p><p>b) تفاعلات الجهاز التنفسي, مثل الربو, أو تفاقم الربو, أو التشنج القصبي,أو ضيق التنفس,</p><p>c) تفاعلات جلدية مختلفة, على سبيل المثال طفح جلدى مختلف الأشكال, أو حكة, أو شرى، أو فرفرية أو وذمة وعائية وأمراض جلدية أقل شيوعاً مثل الأمراض الجلدية التقشرية والفقاعية (وتشمل انحلال البشرة والحمامي عديدة الأشكال).</p><p>أعراض القلب والأوعية الدموية:</p><p>قد تم الإبلاغ عن حدوث وذمة وارتفاع ضغط الدم وفشل القلب التى ترتبط مع العلاج بواسطة مضادات الالتهاب غير الإستيرويدية (NSAIDs).</p><p>التجارب السريرية والمعلومات الوبائية تشير إلى أن استخدام الأيبوبروفين (خصوصاً بجرعات عالية 2400 ملجم يومياً) والعلاج على المدى الطويل قد يترافق مع زيادة طفيفة فى خطر حدوث الجلطات في الشرايين (على سبيل المثال احتشاء عضلة القلب أو السكتة الدماغية). وبشكل عام, الدراسات الوبائية تشير إلى أن استخدام أيبوبروفين بجرعات قليلة (مثلاً جرعة أقل من أو تساوى 1200 ملجم يومياً) لا يصاحبه خطر الإصابة باحتشاء عضلة القلب.</p><p>بالنسبة للمرضى المصابين بارتفاع ضغط الدم غير المنضبط, وفشل القلب الاحتقاني, وأمراض القلب الناتجة عن نقص التروية, وأمراض الشرايين الطرفية, و / أو الأمراض الدماغية الوعائية ينبغي علاجهم بواسطة أيبوبروفين فقط بعد دراسة متأنية. وينبغي الاعتبار بشكل مماثل قبل بدء العلاج على المدى الطويل للمرضى الذين يعانون من عوامل الخطر لأمراض القلب والأوعية الدموية (مثل ارتفاع ضغط الدم والدهون في الدم وداء السكري والتدخين).</p><p>أعراض جانبية أخرى قد تم الإبلاغ عنها بشكل أقل شيوعاً والتى ليس من الضرورى أن تكون مرتبطة بهذا الدواء وتشمل:</p><p>أعراض الكلى: سمية كلوية بأشكال مختلفة, بما في ذلك التهاب الكلية الخلالي, والمتلازمة الكلوية والفشل الكلوي.</p><p>أعراض الكبد: خلل فى وظائف الكبد, والتهاب الكبد واليرقان.</p><p>أعراض عصبية حسية: اضطرابات بصرية, والتهاب العصب البصري, وصداع, ومذل, واكتئاب, وارتباك, وهلوسة, وطنين, ودوار, ودوخة، وشعور بالضيق والتعب والنعاس.</p><p>أعراض الدم: نقص الصفيحات, قلة العدلات, ندرة المحببات, فقر الدم اللاتنسجي وفقر الدم الانحلالي.</p><p>أعراض جلدية: حساسية الجلد للضوء.</p><p>يمكن الحد من حدوث الأعراض الجانبية عبر استخدام أقل جرعة ممكنة لأقل وقت ممكن للسيطرة على الأعراض التى لديك.</p><p>إذا لاحظت تفاقم أى أعراض جانبية لهذا الدواء, أو لاحظت حدوث أى أعراض جانبية لم يتم ذكرها فى هذه النشرة, توقف عن تناول هذا الدواء وأخبر طبيبك المعالج فى الحال.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsAr">5. طريقة تخزين المستحضر</label>
        </div>
        <div class="m-r-60">
            <p>يحفظ هذا الدواء فى درجة حرارة أقل من 30 درجة مئوية.</p><p>يحفظ هذا الدواء فى عبوته الأصلية.</p><p>يحفظ هذا الدواء فى مكان آمن, بعيداً عن نظر ومتناول الأطفال, من الأفضل فى خزانة مغلقة.</p><p>لا تستخدم هذا الدواء بعد انتهاء تاريخ الصلاحية المدون على العبوة. علماً بأن تاريخ الصلاحية يشير إلى آخر يوم فى الشهر المذكور.</p><p>ينبغي عدم التخلص من الأدوية عبر مياه الصرف الصحي أو النفايات المنزلية. اسأل الصيدلي عن كيفية التخلص من الأدوية التي لم تعد مطلوبة. وسوف تساعد هذه التدابير فى حماية البيئة.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: right">6. معلومات أخرى</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsAr">أ‌. على ماذا يحتوي هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p>&middot; سابوفين 200 ملجم أقراص مغلفة بطبقة رقيقة: يحتوى كل قرص على أيبوبروفين 200 ملجم كمادة فعالة.</p><p>مكونات أخرى:</p><p>&middot; لب القرص: هيدروكسى بروبيل سليولوز, ثاني أكسيد سيليكون غروي, أفيسيل PH 101, كبريتات لوريل الصوديوم, كروسكار ميللوز الصوديوم نوع A, أفيسيل PH 102, تلك منقى, بوليسوربيت 80, ثاني أكسيد التيتانيوم, بولي إيثيلين جلايكول 6000 وهيدروكسي بروبيل ميثيل سليولوز.</p><p>&middot; غلاف القرص: أوبادرى برتقالى قاتم ومياه منقاة.</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsAr">ب‌. كيف يبدو شكل هذا المستحضر وماهي محتويات العلبة</label>
        </div>
        <div class="m-r-60">
            <p>- سابوفين 200 ملجم أقراص مغلفة بطبقة رقيقة: أقراص دائرية مغلفة بطبقة رقيقة لونها من أبيض إلى أبيض فاتح, ثنائية التحدب, مكتوب على أحد الجانبين &quot;177&quot; وسطحها جلى من الجانب الآخر. محتويات العبوة: سابوفين 200 ملجم أقراص مغلفة بطبقة رقيقة: تحتوى كل عبوة على 30 قرصاً.</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingAr">ت‌. الشركة المصنعة ومالك حق التسويق</label>
        </div>
        <div class="m-r-60">
            <p>الدوائية</p><p>مصنع الأدوية بالقصيم</p><p>الشركة السعودية للصناعات الدوائية والمستلزمات الطبية.</p><p>المملكة العربية السعودية</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteAr">ث‌. تمت مراجعة هذه النشرة في التاريخ الذي تمت فيه مراجعة النشرة بالشهر والسنة</label>
        </div>
        <div class="m-r-60">
             مارس 2016.
        </div>
    </div>
</div>
    </div>
    <div id="M-div" class="box-data">


    <div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr"><i class="fa fa-info-circle"></i>&nbsp;Read this leaflet carefully before you start using this product as it contains important information for you</div>
    </div>
<div class="row clearfix ltr">

    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="MedicinalName">1. NAME OF THE MEDICINAL PRODUCT </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Sapofen 200 mg.
Film-coated tablets.

            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="QualitativeQuantitativeComposition">2. QUALITATIVE AND QUANTITATIVE COMPOSITION </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Sapofen 200 mg film-coated tablets: each film-coated tablet contains 200 mg Ibuprofen as an active ingredient. 
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="DosageForm">3. PHARMACEUTICAL FORM </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Sapofen 200mg FCTablets: A white to off white, round, biconvex, film coated tablet with “177” on one side and plain on the other side.
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">4. CLINICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="TherapeuticIndications">4.1 Therapeutic Indications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>For its analgesic anti-inflammatory effects in the treatment of rheumatoid arthritis (including juvenile rheumatoid arthritis or Still&#39;s disease), ankylosing spondylitis, osteoarthritis, other non-rheumatoid (seronegative) arthropathies. In the treatment of non-articular rheumatic conditions, ibuprofen is indicated in periarticular conditions such as frozen shoulder (capsulitis), bursitis, tendinitis, tenosynovitis, low back pain and soft tissue injuries such as sprains and strains.</p><p>Ibuprofen is also indicated for its analgesic effect in the relief of mild to moderate pain such as dysmenorrhoea, dental and post-operative pain and for the symptomatic relief of headache, including migraine headache.</p><p>For the relief of pain of non-serious arthritic conditions and for the relief of rheumatic or muscular pain, backache, neuralgia, headache including migraine headache, dental pain, dysmenorrhoea, feverishness and the symptoms of colds and influenza.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PosologyAndMethodAdministration">4.2 Posology And Method Administration</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>For oral administration.</p><p>To be taken preferably with or after food.</p><p>Undesirable effects may be minimised by using the lowest effective dose for the shortest duration necessary to control symptoms (see section 4.4).</p><p><u>Adults and Children over 12 years:</u></p><p>The recommended dosage is 1200-1800mg daily in divided doses. Some patients can be maintained on 600-1200mg daily. In severe or acute conditions it can be advantageous to increase the dosage until the acute phase is brought under control, provided that the daily dose does not exceed 2400mg in divided doses.</p><p><u>Children under 12 years:</u></p><p>The daily dosage is 20mg/kg of body weight in divided doses.</p><p>In juvenile rheumatoid arthritis up to 40mg/kg of body weight daily in divided doses may be taken. Not recommended for children weighing less than 7kg.</p><p><u>Elderly:</u></p><p>No special dosage modifications are required, unless renal or hepatic function is impaired, in which case dosage should be assessed individually.</p><p>The elderly are at increased risk of the serious consequences of adverse reactions. If an NSAID is considered necessary, the lowest effective dose should be used and for the shortest possible duration. The patient should be monitored regularly for GI bleeding during NSAID therapy.</p><p>For oral administration and short-term use only.</p><p><u>Adults, the elderly and children over 12 years</u>:</p><p>The lowest effective dose should be used for the shortest possible duration necessary to relieve symptoms. The patient should consult a doctor if symptoms persist or worsen, or if the product is required for more than 10 days.</p><p>One tablet to be taken up to three times a day, as required.</p><p>Leave at least four hours between doses and do not take more than 3 tablets (1200mg) in any 24 hour period.</p><p><u>Children under 12 years</u>:</p><p>Not suitable for children under 12 years.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Contraindications">4.3 Contraindications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Hypersensitivity to ibuprofen or any of the excipients in the product.
Patients who have previously shown hypersensitivity reactions (e.g. asthma, rhinitis, angioedema or urticaria), in response to ibuprofen, aspirin or other non-steroidal anti-inflammatory drugs.
Active or history of recurrent peptic ulcer/haemorrhage (two or more distinct episodes of proven ulceration or bleeding).
History of gastrointestinal bleeding or perforation, related to previous NSAIDs therapy.
Severe heart failure, renal failure or hepatic failure (see section 4.4).
Last trimester of pregnancy (see section 4.6).
Children under 12 years.
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialWarnings">4.4. Special warnings and precautions for use</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Undesirable effects may be minimised by using the lowest effective dose for the shortest duration necessary to control symptoms (see section 4.2 and GI and cardiovascular risks below).</p><p>The use of ibuprofen with concomitant NSAIDs including cyclo-oxygenase-2 selective inhibitors should be avoided (see section 4.5).</p><p><em>Elderly:</em></p><p>The elderly have an increased frequency of adverse reactions to NSAIDs especially gastrointestinal bleeding and perforation, which may be fatal (see section 4.2).</p><p><em>Respiratory disorders:</em></p><p>Caution is required if administered to patients suffering from, or with a previous history of, bronchial asthma, since NSAIDs have been reported to precipitate bronchospasm in such patients.</p><p><em>Cardiovascular, Renal and Hepatic impairment:</em></p><p>The administration of an NSAID may cause a dose dependent reduction in prostaglandin formation and precipitate renal failure. Patients at greatest risk of this reaction are those with impaired renal function, cardiac impairment, liver dysfunction, those taking diuretics and the elderly. Renal function should be monitored in these patients (see also section 4.3).</p><p><em>Cardiovascular and cerebrovascular effects:</em></p><p>Appropriate monitoring and advice are required for patients with a history of hypertension and/or mild to moderate congestive heart failure as fluid retention and oedema have been reported in association with NSAID therapy.</p><p>Clinical trial data suggest that use of ibuprofen, particularly at a high dose (2400mg daily) and in long-term treatment may be associated with a small increased risk of arterial thrombotic events (for example myocardial infarction or stroke). Overall, epidemiological studies do not suggest that low dose ibuprofen (e.g. &le; 1200mg daily) is associated with an increased risk of myocardial infarction.</p><p>Patients with uncontrolled hypertension, congestive heart failure, established ischaemic heart disease, peripheral arterial disease, and/or cerebrovascular disease should only be treated with ibuprofen after careful consideration. Similar consideration should be made before initiating longer-term treatment of patients with risk factors for cardiovascular events (e.g. hypertension, hyperlipidaemia, diabetes mellitus, smoking).</p><p><em>Gastrointestinal bleeding, ulceration and perforation:</em></p><p>GI bleeding, ulceration or perforation, which can be fatal, has been reported with all NSAIDs at any time during treatment, with or without warning symptoms or a previous history of serious GI events.</p><p>The risk of GI bleeding, ulceration or perforation is higher with increasing NSAID doses, in patients with a history of ulcer, particularly if complicated with haemorrhage or perforation (see section 4.3), and in the elderly. These patients should commence treatment on the lowest dose available. Combination therapy with protective agents (e.g. misoprostol or proton pump inhibitors) should be considered for these patients, and also for patients requiring concomitant low dose aspirin, or other drugs likely to increase gastrointestinal risk (see below and section 4.5).</p><p>Patients with a history of GI toxicity, particularly when elderly, should report any unusual abdominal symptoms (especially GI bleeding) particularly in the initial stages of treatment.</p><p>Caution should be advised in patients receiving concomitant medications which could increase the risk of ulceration or bleeding, such as oral corticosteroids, anticoagulants such as warfarin, selective serotonin-reuptake inhibitors, or anti-platelet agents such as aspirin (see section 4.5).</p><p>When GI bleeding or ulceration occurs in patients receiving ibuprofen, the treatment should be withdrawn.</p><p>NSAIDs should be given with care to patients with a history of gastrointestinal disease (ulcerative colitis, Crohn&#39;s disease) as these conditions may be exacerbated (see section 4.8).</p><p><em>SLE and mixed connective tissue disease:</em></p><p>In patients with systemic lupus erythematosus (SLE) and mixed connective tissue disorders there may be an increased risk of aseptic meningitis (see section 4.8).</p><p><em>Dermatological:</em></p><p>Serious skin reactions, some of them fatal, including exfoliative dermatitis, Stevens-Johnson syndrome, and Toxic Epidermal Necrolysis, have been reported very rarely in association with the use of NSAIDs (see section 4.8). Patients appear to be at highest risk for these reactions early in the course of therapy: the onset of the reaction occurring in the majority of cases within the first month of treatment. Ibuprofen should be discontinued at the first appearance of skin rash, mucosal lesions, or any other sign of hypersensitivity.</p><p>Exceptionally, varicella can be at the origin of serious cutaneous and soft tissue infectious complications. To date, the contributing role of NSAIDs in the worsening of these infections cannot be ruled out. Thus, it is advisable to avoid use of Ibuprofen in case of varicella (see section 4.8).</p><p><em>Impaired female fertility:</em></p><p>The use of ibuprofen may impair female fertility and is not recommended in women attempting to conceive. In women who have difficulties conceiving or who are undergoing investigation of infertility, withdrawal of ibuprofen should be considered.</p><p>Undesirable effects may be minimised by using the lowest effective dose for the shortest duration necessary to control symptoms (see GI and cardiovascular risks below).</p><p>The elderly have an increased frequency of adverse reactions to NSAIDs especially gastrointestinal bleeding and perforation which may be fatal.</p><p><em>Respiratory:</em></p><p>Bronchospasm may be precipitated in patients suffering from or with a previous history of bronchial asthma or allergic disease.</p><p><em>Other NSAIDs:</em></p><p>The use of ibuprofen with concomitant NSAIDs including cyclo-oxygenase-2 selective inhibitors should be avoided (see section 4.5).</p><p><em>SLE and mixed connective tissue disease:</em></p><p>Systemic lupus erythematosus and mixed connective tissue disease - increased risk of aseptic meningitis (see section 4.8)</p><p><em>Renal:</em></p><p>Renal impairment as renal function may further deteriorate (see sections 4.3 and 4.8)</p><p><em>Hepatic:</em></p><p>Hepatic dysfunction (see sections 4.3 and 4.8)</p><p><em>Cardiovascular and cerebrovascular effects:</em></p><p>Caution (discussion with doctor or pharmacist) is required prior to starting treatment in patients with a history of hypertension and/or heart failure as fluid retention, hypertension and oedema have been reported in association with NSAID therapy.</p><p>Clinical trial and epidemiological data suggest that use of ibuprofen, particularly at high doses (2400mg daily) and in long-term treatment may be associated with a small increased risk of arterial thrombotic events (for example myocardial infarction or stroke). Overall, epidemiological studies do not suggest that low dose ibuprofen (e.g. &le; 1200mg daily) is associated with an increased risk of myocardial infarction.</p><p><em>Impaired female fertility:</em></p><p>There is limited evidence that drugs which inhibit cyclo-oxygense/prostaglandin synthesis may cause impairment of female fertility by an effect on ovulation. This is reversible on withdrawal of treatment.</p><p><em>Gastrointestinal:</em></p><p>NSAIDs should be given with care to patients with a history of gastrointestinal disease (ulcerative colitis, Crohn&#39;s disease) as these conditions may be exacerbated (see section 4.8).</p><p>GI bleeding, ulceration or perforation, which can be fatal, has been reported with all NSAIDs at anytime during treatment, with or without warning symptoms or a previous history of serious GI events.</p><p>The risk of GI bleeding, ulceration or perforation is higher with increasing NSAID doses, in patients with a history of ulcer, particularly if complicated with haemorrhage or perforation (see section 4.3), and in the elderly. These patients should commence treatment on the lowest dose available.</p><p>Patients with a history of GI toxicity, particularly when elderly, should report any unusual abdominal symptoms (especially GI bleeding) particularly in the initial stages of treatment.</p><p>Caution should be advised in patients receiving concomitant medications which could increase the risk of ulceration or bleeding, such as oral corticosteroids, anticoagulants such as warfarin, selective serotonin-reuptake inhibitors or anti-platelet agents such as aspirin (see section 4.5).</p><p>When GI bleeding or ulceration occurs in patients receiving ibuprofen, the treatment should be withdrawn.</p><p><em>Dermatological:</em></p><p>Serious skin reactions, some of them fatal, including exfoliative dermatitis, Stevens-Johnson syndrome, and Toxic Epidermal Necrolysis, have been reported very rarely in association with the use of NSAIDSs (see section 4.8). Patients appear to be at highest risk for these reactions early in the course of therapy: the onset of the reaction occurring in the majority of cases within the first month of treatment. Ibuprofen should be discontinued at the first appearance of skin rash, mucosal lesions, or any other sign of hypersensitivity.</p><p>Exceptionally, varicella can be at the origin of serious cutaneous and soft tissue infectious complications. To date, the contributing role of NSAIDs in the worsening of these infections cannot be ruled out. Thus, it is advisable to avoid use of Ibuprofen in case of varicella (see section 4.8).</p><p>The label will include:</p><p>Read the enclosed leaflet before taking this product</p><p>Do not take if you:</p><p>&bull; Have (or have had two or more episodes of) a stomach ulcer, perforation or bleeding</p><p>&bull; Are allergic to ibuprofen or any other ingredient of the product, aspirin or other related painkillers</p><p>&bull; Are taking other NSAID painkillers, or aspirin with a daily dose above 75 mg</p><p>Speak to a pharmacist or your doctor before taking if you:</p><p>&bull; Have or have had asthma, diabetes, high cholesterol, high blood pressure, a stroke, heart, liver, kidney or bowel problems</p><p>&bull; Are a smoker</p><p>&bull; Are pregnant</p><p>If symptoms persist or worsen, consult your doctor.</p><p>Patients with obstructive bowel disorders or acute abdominal conditions should consult a doctor before using this product.</p><p>Patients with a history of cholecystectomy should consult a doctor before using this product as it may cause acute pancreatitis in some patients.</p><p>&nbsp;</p><p>This medicine is for the short term treatment of acute moderate pain when other painkillers have not worked.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="InteractionsOtherMedicines">4.5. Interactions with other medicinal products</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><em>Other analgesics including cyclo-oxygenase-2 selective inhibitors:</em>&nbsp;Avoid concomitant use of two or more NSAIDs (including aspirin) as this may increase the risk of adverse effects (see section 4.4).</p><p><em>Anti-hypertensives:</em>&nbsp;Reduced anti-hypertensive effect.</p><p><em>Diuretics:</em>&nbsp;Reduced diuretic effect. Diuretics can increase the risk of nephrotoxicity of NSAIDs.</p><p><em>Cardiac glycosides:</em>&nbsp;NSAIDs may exacerbate cardiac failure, reduce GFR and increase plasma cardiac glycoside levels.</p><p><em>Lithium:</em>&nbsp;Decreased elimination of lithium.</p><p><em>Methotrexate:</em>&nbsp;Decreased elimination of methotrexate.</p><p><em>Ciclosporin:</em>&nbsp;Increased risk of nephrotoxicity.</p><p><em>Mifepristone:</em>&nbsp;NSAIDs should not be used for 8-12 days after mifepristone administration as NSAIDs can reduce the effects of mifepristone.</p><p><em>Corticosteroids:</em>&nbsp;Increased risk of gastrointestinal ulceration or bleeding (see section 4.4).</p><p><em>Anticoagulants:</em>&nbsp;NSAIDs may enhance the effects of anti-coagulants, such as warfarin (see section 4.4).</p><p><em>Quinolone antibiotics:</em>&nbsp;Animal data indicate that NSAIDs can increase the risk of convulsions associated with quinolone antibiotics. Patients taking NSAIDs and quinolones may have an increased risk of developing convulsions.</p><p><em>Anti-platelet agents and selective serotonin-reuptake inhibitors (SSRIs):</em>&nbsp;Increased risk of gastrointestinal bleeding (see section 4.4).</p><p><em>Tacrolimus:</em>&nbsp;Possible increased risk of nephrotoxicity when NSAIDs are given with tacrolimus.</p><p><em>Zidovudine:</em>&nbsp;Increased risk of haematological toxicity when NSAIDs are given with zidovudine. There is evidence of an increased risk of haemarthroses and haematoma in HIV(+) haemophiliacs receiving concurrent treatment with zidovudine and ibuprofen.</p><p>Experimental data suggest that ibuprofen may inhibit the effect of low dose aspirin on platelet aggregation when they are dosed concomitantly. However, the limitations of these data and the uncertainties regarding extrapolation of ex vivo data to the clinical situation imply that no firm conclusions can be made for regular ibuprofen use, and no clinically relevant effect is considered to be likely for occasional ibuprofen use (see section 5.1).</p><p><strong>Ibuprofen should be avoided in combination with:</strong></p><p><em>Aspirin:</em>&nbsp;Unless low-dose aspirin (not above 75mg daily) has been advised by a doctor, as this may increase the risk of adverse reactions (see section 4.4).</p><p><em>Other NSAIDS including cyclo-oxygenase-2 selective inhibitors</em>: Avoid concomitant use of two or more NSAIDs as this may increase the risk of adverse effects (see section 4.4).</p><p><strong>Ibuprofen should be used with caution in combination with:</strong></p><p><em>Anticoagulants:</em>&nbsp;NSAIDS may enhance the effects of anti-coagulants, such as warfarin (see section 4.4).</p><p><em>Antihypertensives and diuretics</em>: NSAIDs may diminish the effect of these drugs. Diuretics can increase the risk of nephrotoxicity of NSAIDs.</p><p><em>Corticosteroids:</em>&nbsp;Increased risk of gastrointestinal ulceration or bleeding (see section 4.4).</p><p><em>Anti-platelet agents and selective serotonin reuptake inhibitors (SSRIs):</em></p><p>Increased risk of gastrointestinal bleeding (see section 4.4)</p><p><em>Cardiac glycosides:</em>&nbsp;NSAIDs may exacerbate cardiac failure, reduce GFR and increase plasma glycoside levels.</p><p><em>Lithium:&nbsp;</em>There is evidence for potential increases in plasma levels of lithium.</p><p><em>Methotrexate:</em>&nbsp;There is a potential for an increase in plasma methotrexate.</p><p><em>Ciclosporin:</em>&nbsp;Increased risk of nephrotoxicity.</p><p><em>Mifepristone:</em>&nbsp;NSAIDs should not be used for 8-12 days after mifepristone administration as NSAIDs can reduce the effect of mifepristone.</p><p><em>Tacrolimus:&nbsp;</em>Possible increased risk of nephrotoxicity when NSAIDs are given with tacrolimus.</p><p><em>Zidovudine:</em>&nbsp;Increased risk of haematological toxicity when NSAIDs are given with zidovudine. There is evidence of an increased risk of haemarthroses and haematoma in HIV(+) haemophiliacs receiving concurrent treatment with zidovudine and ibuprofen.</p><p><em>Quinolone antibiotics:&nbsp;</em>Animal data indicate that NSAIDs can increase the risk of convulsions associated with quinolone antibiotics. Patients taking NSAIDs and quinolones may have an increased risk of developing convulsions.</p><p>Experimental data suggest that ibuprofen may inhibit the effect of low dose aspirin on platelet aggregation when they are dosed concomitantly. However, the limitations of these data and the uncertainties regarding extrapolation of ex vivo data to the clinical situation imply that no firm conclusions can be made for regular ibuprofen use, and no clinically relevant effect is considered to be likely for occasional ibuprofen use (see section 5.1).</p><p>Excessive intake of caffeine (e.g. coffee, tea and some canned drinks) should be avoided while taking this product.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="FertilityAndPregnantWarnings">4.6. Fertility, pregnancy and lactation</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><strong>Pregnancy</strong></p><p>Congenital abnormalities have been reported in association with NSAID administration in man; however, these are low in frequency and do not appear to follow any discernible pattern. In view of the known effects of NSAIDs on the foetal cardiovascular system (risk of closure of the ductus arteriosus) use in the last trimester of pregnancy is contraindicated. The onset of labour may be delayed and the duration increased with an increased bleeding tendency in both mother and child (see section 4.3). NSAIDs should not be used during the first two trimesters of pregnancy or labour unless the potential benefits to the patient outweighs the potential risk to the foetus.</p><p>Whilst no teratogenic effects have been demonstrated in animal experiments, the use of ibuprofen should, if possible, be avoided during the first 6 months of pregnancy.</p><p>During the 3rd trimester, ibuprofen is contraindicated as there is there is a risk of premature closure of the foetal ductus arteriosus with possible persistent pulmonary hypertension. The onset of labour may be delayed and the duration increased with an increased bleeding tendency in both mother and child (see section 4.3).</p><p><strong>Lactation</strong></p><p>In limited studies so far available, NSAIDs can appear in breast milk in very low concentrations. NSAIDs should, if possible, be avoided when breastfeeding.</p><p>In limited studies, ibuprofen appears in the breast milk in very low concentration and is unlikely to affect the breast-fed infant adversely.</p><p>See section 4.4 regarding female fertility.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="EffectsAbilityDriveMachines">4.7. Effects on ability to drive and use machines</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Undesirable effects such as dizziness, drowsiness, fatigue and visual disturbances are possible after taking NSAIDs. If affected, patients should not drive or operate machinery.</p><p>None expected at recommended doses and duration of therapy.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="UndesirableEffects">4.8. Undesirable effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>The following frequencies are taken as a basis when evaluating undesirable effects:</p><table border="0" cellspacing="0" cellpadding="0" style="width:692px"><tbody><tr><td style="vertical-align:top"><p>Very common:</p></td><td style="vertical-align:top"><p>&ge; 1/10</p></td></tr><tr><td style="vertical-align:top"><p>Common:</p></td><td style="vertical-align:top"><p>&ge; 1/100 to &lt; 1/10</p></td></tr><tr><td style="vertical-align:top"><p>Uncommon:</p></td><td style="vertical-align:top"><p>&ge; 1/1,000 to &lt; 1/100</p></td></tr><tr><td style="vertical-align:top"><p>Rare:</p></td><td style="vertical-align:top"><p>&ge; 1/10,000 to &lt; 1/1,000</p></td></tr><tr><td style="vertical-align:top"><p>Very rare:</p></td><td style="vertical-align:top"><p>&gt; 1/10,000</p></td></tr><tr><td style="vertical-align:top"><p>Not known:</p></td><td style="vertical-align:top"><p>cannot be estimated from the available data.</p><p>&nbsp;</p></td></tr></tbody></table><p>Gastrointestinal: the most commonly-observed adverse events are gastrointestinal in nature. Nausea, vomiting, diarrhoea, dyspepsia, abdominal pain, melaena, haematemesis, ulcerative stomatitis and gastrointestinal haemorrhage have been reported following ibuprofen administration. Less frequently, gastritis, duodenal ulcer, gastric ulcer and gastrointestinal perforation have been observed. Epidemiological data indicate that of the seven most widely used oral, non-aspirin NSAIDs; ibuprofen presents the lowest risk of upper gastrointestinal toxicity.</p><p>&nbsp;</p><p>Hypersensitivity: hypersensitivity reactions have been reported following treatment with ibuprofen. These may consist of (a) non-specific allergic reaction and anaphylaxis, (b) respiratory tract reactivity comprising asthma, aggravated asthma, bronchospasm or dyspnoea, or (c) assorted skin disorders, including rashes of various types, pruritus, urticaria, purpura, angioedema and, less commonly, bullous dermatoses (including epidermal necrolysis and erythema multiforme).</p><p>&nbsp;</p><p>Cardiovascular: Oedema, hypertension and cardiac failure have been reported in association with NSAID treatment. Clinical trial and epidemiological data suggest that use of ibuprofen, particularly at high dose (2400 mg/ daily), and in long term treatment may be associated with a small increased risk of arterial thrombotic events (for example myocardial infarction or stroke).</p><p>&nbsp;</p><p>Other adverse events reported less commonly and for which causality has not necessarily been established include:</p><p>&nbsp;</p><p>Renal: nephrotoxicity in various forms, including interstitial nephritis, nephrotic syndrome and renal failure.</p><p>&nbsp;</p><p>Hepatic: abnormal liver function, hepatitis and jaundice.</p><p>&nbsp;</p><p>Neurological and special senses: visual disturbances, optic neuritis, headaches, paraesthesia, depression, confusion, hallucinations, tinnitus, vertigo, dizziness, malaise, fatigue and drowsiness.</p><p>&nbsp;</p><p>Haematological: thrombocytopenia, neutropenia, agranulocytosis, aplastic anaemia and haemolytic anaemia.</p><table border="1" cellspacing="0" cellpadding="0"><tbody><tr><td style="vertical-align:top"><p><strong>To report any side effect(s):</strong></p><p> The National Pharmacovigilance and Drug Safety Centre (NPC)</p><p>o Fax: +966-11-205-7662</p><p>o Call NPC at +966-11-2038222, Exts: 2317-2356-2353-2354-2334-2340.</p><p>o Toll free phone: 8002490000</p><p>o E-mail: npc.drug@sfda.gov.sa</p><p>o Website: www.sfda.gov.sa/npc</p><p>&nbsp;</p></td></tr></tbody></table><p><br />&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Overdoes">4.9. Overdoes</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>In children ingestion of more than 400 mg/kg may cause symptoms. In adults the dose response effect is less clear cut. The half-life in overdose is 1.5-3 hours.</p><p><strong>Symptoms</strong></p><p>Most patients who have ingested clinically important amounts of NSAIDs will develop no more than nausea, vomiting, epigastric pain, or more rarely diarrhoea. Tinnitus, headache and gastrointestinal bleeding are also possible. In more serious poisoning, toxicity is seen in the central nervous system, manifesting as drowsiness, occasionally excitation and disorientation or coma. Occasionally patients develop convulsions. In serious poisoning metabolic acidosis may occur and the prothrombin time/INR may be prolonged, probably due to interference with the actions of circulating clotting factors. Acute renal failure and liver damage may occur. Exacerbation of asthma is possible in asthmatics.</p><p><strong>Management</strong></p><p>Management should be symptomatic and supportive and include the maintenance of a clear airway and monitoring of cardiac and vital signs until stable. Consider oral administration of activated charcoal if the patient presents within 1 hour of ingestion of a potentially toxic amount. If frequent or prolonged, convulsions should be treated with intravenous diazepam or lorazepam. Give bronchodilators for asthma.</p>
            </div>
        </div>
    </div>

    <div class="col-xs-12">
        <label style="float: left">5. PHARMACOLOGICAL PROPERTIES</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PharmacodynamicProperties">5.1. Pharmacodynamic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Ibuprofen is a propionic acid derivative NSAID that has demonstrated its efficacy by inhibition of prostaglandin synthesis. In humans ibuprofen reduces inflammatory pain, swellings and fever. Furthermore, ibuprofen reversibly inhibits platelet aggregation.</p><p>Experimental data suggest that ibuprofen may inhibit the effect of low dose aspirin on platelet aggregation when they are dosed concomitantly. In one study, when a single dose of ibuprofen 400 mg was taken within 8 h before or within 30 min after immediate release aspirin dosing (81 mg), a decreased effect of ASA on the formation of thromboxane or platelet aggregation occurred. However, the limitations of these data and the uncertainties regarding extrapolation of ex vivo data to the clinical situation imply that no firm conclusions can be made for regular ibuprofen use, and no clinically relevant effect is considered to be likely for occasional ibuprofen use.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
                <label style="float: left" for="PharmacokineticProperties">5.2. Pharmacokinetic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Ibuprofen is rapidly absorbed following administration and is rapidly distributed throughout the whole body. The excretion is rapid and complete via the kidneys.</p><p>Maximum plasma concentrations are reached 45 minutes after ingestion if taken on an empty stomach. When taken with food, peak levels are observed after 1 to 2 hours. These times may vary with different dosage forms.</p><p>The half-life of ibuprofen is about 2 hours.</p><p>In limited studies, ibuprofen appears in the breast milk in very low concentrations.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PreclinicalSafetyData">5.3 Preclinical Safety Data</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>There are no preclinical data of relevance to the prescriber which are additional to that already included.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. PHARMACEUTICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ExcipientsList">6.1 Excipients List</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Hydroxypropyl Cellulose, Colloidal Silicon Dioxide, Avicel PH 101, Sodium Lauryl Sulphate, Croscarmellose Sodium Type A, Avicel PH 102, Purified Talc, Polysorbate 80, Titanium Dioxide, Polyethylene Glycol and Hydroxypropyl Methylcellulose.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Incompatibilities">6.2. Incompatibilities</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <table border="0" cellpadding="0" style="width:730px"><tbody><tr><td><p>Not applicable.</p></td></tr></tbody></table>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ShelfLife">6.3. Shelf Life</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Sapofen 200 mg film-coated tablets: 36Months/3Years.
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PrecautionsStorageConditions">6.4. Special precautions for storage</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Sapoefen 200 mg : store below 25&deg;C.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ContainerContents">6.5. Nature and contents of container</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Sapofen 200 mg film-coated tablets: 30 tablets /pack.</p><p>White Opaque PVC/PVDC Blister Strip and Aluminium Foil</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialPrecautionsDisposal">6.6. Special precautions for disposal and other handling</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>No Special Disposal</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="AuthorizationMarketingHolder">7. MARKETING AUTHORISATION HOLDER</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                SPIMACO
AlQassim pharmaceutical plant

Saudi Pharmaceutical Industries &
Medical Appliance Corporation

            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="RevisionDateText">8. DATE OF REVISION OF THE TEXT</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                November 2016  
            </div>
        </div>
    </div>
</div>

            }    </div>
    <div id="f-div" class="box-data">
        
<div class="row clearfix rtl">
    <div class="container-fluid">
        <!-- Basic Example -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>صورة المنتج على الرف</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic" data-slide-to="0" class="active"></li>
                        <li data-target="#carousel-example-generic" data-slide-to="1" class=""></li>
                        <li data-target="#carousel-example-generic" data-slide-to="2" class=""></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                            
                                <img src="/images/nodrugimags.png">
                        </div>

                    </div>

                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# Basic Example -->
        <!-- With Captions -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>الصورة الاساسية</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic_2" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic_2" data-slide-to="0" class=""></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="1" class="active"></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="2"></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                                <img src="/images/nodrugimags.png">
                        </div>
                    </div>
                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic_2" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic_2" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# With Captions -->
    </div>
</div>


    </div>

    <!-- #END# Tabs With Custom Animations -->
</div>
        <a style="background-image: url('../images/banner.png');"
           class="scroll-top">
            <img style="margin: 15px;" src="/images/icons/up-arrow2.png" width="35">
        </a>

        <div class="footer navbar-fixed-bottom">
            <small style="color: white; margin-left: 30px;">All Rights Reserved - SFDA &copy; 2020</small>
            <br class="visible-xs visible-sm"><br class="visible-xs visible-sm">

        </div>
    </section>


    <script src="/lib/json2/json2.js?v=w3DjWhUtDqy3bSJKv285C-2kagUtW9F64T9z3xRah8g"></script>
    <script src="/lib/jquery/dist/jquery.js?v=w4hyv6-vmv08RC2hK00wXgxDziKII9paMAbU_M-5dgY"></script>
    <script src="/lib/bootstrap/dist/js/bootstrap.js?v=T574NvJTWc-Pan8hAmnXXc0eZFiqKRp7xQ3sz5QiFOk"></script>
    <script src="/lib/moment/min/moment-with-locales.js?v=5f0RFtuChrGi6osDzegxXWf5yOkmx45i7J9fM1p6P5w"></script>
    <script src="/lib/jquery-validation/dist/jquery.validate.js?v=ZDzsHzuLAtqQVxXwbgRtfAPXQ7UAoJRXBAUDvc9G9CI"></script>
    <script src="/lib/blockUI/jquery.blockUI.js?v=KKcUNqwNyTLaXzvuMyFk6JisiQq6Hk7ZtrciXnEf3Z0"></script>
    <script src="/lib/toastr/toastr.js?v=s1ewxfN8Vn23TAVRLUk8XiQUAw6uWhhuPO9dmtYzUiA"></script>
    <script src="/lib/sweetalert/dist/sweetalert.min.js?v=aPktydUv1rN3mouQeXoKi3ioFTIQlULuqYeoTAA2ihY"></script>
    <script src="/lib/spin.js/spin.js?v=b1plKpQIB-XuGyjWec42MhmhpPzEPzFI3OC8Ia0XIoc"></script>
    <script src="/lib/spin.js/jquery.spin.js?v=i7H7HL08ldqUANgfQInE7LlU2uWUdQMCJ-Q7-_zLutY"></script>
    <script src="/lib/bootstrap-select/dist/js/bootstrap-select.js?v=tXulJKckrq2j2wo8a9hvmXLDEQwhGviPTIYmEzy1dNI"></script>
    <script src="/lib/jquery-slimscroll/jquery.slimscroll.js?v=ESVSX4dkOxamaRoYfcqPM2FfErhgfxS60fp1Fa8ou1w"></script>
    <script src="/lib/Waves/dist/waves.js?v=ZOMv1vwqpT_ezNZGhvr9jJTr_jqu3lYHB7vmpxD7HmA"></script>
    <script src="/lib/push.js/push.js?v=w347yqiscLjM_TxUKpqeUA1LDR3w5vshQpxpTsgkLhE"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/abp.js?v=EjNSmvtPSqCVK_xG_aTvOp8hmVM_7vwyd3hg45CAMGk"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.jquery.js?v=XEXcdRYb4eN3XoQCbnM-BSR6UifHRLsXYDIVFZ7Oc6Q"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.toastr.js?v=h3viOCmHM1K7HnYUuJPDvLchk2Ge8CoKvl6ZJfICgII"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.blockUI.js?v=vMuHbqHh635SKL2RG2qsGGCDyHg1yFeGqhPKpS34g4k"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.spin.js?v=djoKib6ssm5DDzbXLe5pD7ayfFg3siaoEk-BFYzQlvI"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.sweet-alert.js?v=fPp3O_ILaqD0UHiR721w1i4iBtxo3NH7yfldI5dg0_I"></script>
    <script src="/js/admin.js?v=nakObLuf3yPs2VlWrIris5w-48c36X3YIRrxIis7IKQ"></script>
    <script src="/js/main.js?v=x_HDlXByl0okIi4i04d4Q_fNr85GPQi1W8gjs82s-n8"></script>
    <script src="/view-resources/Views/Shared/_Layout.js?v=36YkLzPJaGejZMB10f2T6f1rMVIzDKq96kjfcnxcLVg"></script>


        <script src="/lib/jquery-validation/src/localization/messages_ar.js?v=6kzy-p-PtvkHPWdHWyjMOIfwhBFlUYYv9jnF7zJnpUI"></script>

    <!-- Dynamic scripts of ABP system (They are created on runtime and can not be bundled) -->
    <script src="/AbpServiceProxies/GetAll?v=638865394571695575" type="text/javascript"></script>
    <script src="/AbpScripts/GetScripts?v=638865394571695575" type="text/javascript"></script>
    <script src="/lib/signalr-client/signalr.min.js?v=1yGr-J4NjYMQVt6LP6vocjHIWhO-BFQLfdCs8x1Mv-U"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.signalr-client.js?v=jTdZBAadu6DXq0iDTFX6vsn4q6bFhKm3XfN8Jz6dSmg"></script>
    
    <!-- View specific scripts -->
    
    <script src="/view-resources/Views/Home/Index.js?v=mAIakROmG_IlahImCtfrMSdaLPTG5Uoh6Z0hM1g3cxw"></script>
    <script src="/view-resources/Views/Home/Result.js?v=0pEgOuTQc8ZyJaaOpJCG7ytkKSCkzEMYCHEJfKDWu4k"></script>
    <script src="/view-resources/Views/Home/DrugsSearch.js?v=04aRniTG_ClH5tABzf7EDwQgWVpkDNpjeJUDSGvOK_Y"></script>

</body>
</html>